LCM
KRRO icon

Laurion Capital Management’s Korro Bio KRRO Stock Holding History

Laurion Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,387
Closed -$356K – 624
2021
Q4 		$356K Hold
1,387
– – ﹤0.01% 445
2021
Q3 		$490K Sell
1,387
-586
-30% -$231K ﹤0.01% 573
2021
Q2 		$983K Sell
1,973
-934
-32% -$456K 0.01% 445
2021
Q1 		$1.38M Hold
2,907
– – 0.01% 464
2020
Q4 		$5.13M Hold
2,907
– – 0.04% 244
2020
Q3 		$2.79M Hold
2,907
– – 0.03% 275
2020
Q2 		$3.38M Hold
2,907
– – 0.04% 270
2020
Q1 		$2.59M Sell
2,907
-2,093
-42% -$2.26M 0.03% 319
2019
Q4 		$4.38M Buy
+5,000
New +$3.89M 0.03% 329

Other funds holding KRRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Laurion Capital Management's KRRO Position: Q1 2022 in Review

Laurion Capital Management sold out of Korro Bio (KRRO) in Q1 2022, closing a stake of 1,387 shares — an estimated $356K sold.

Laurion Capital Management first reported a position in KRRO in Q4 2019 and held it in 9 quarters. The position peaked at $5.13M in Q4 2020. 85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

  • Laurion Capital Management reported no remaining Korro Bio position as of Q1 2022 after selling out during the quarter.
  • Laurion Capital Management sold 1,387 Korro Bio shares in Q1 2022, an estimated $356K.
  • Laurion Capital Management first reported a position in Korro Bio in Q4 2019 and held it in 9 quarters.
  • Laurion Capital Management's Korro Bio position peaked at $5.13M in Q4 2020.
  • 85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on Laurion Capital Management's 13F filing for Q1 2022, filed 16 May 2022.